Webcast
Live Panel Discussion Replay: The Globalization of Clinical Trials - The Good, The Bad & The Overall Impact on Pharma Development
To view the media player you will need Adobe Flash!
Download Adobe Flash
Download Adobe Flash
The video player is loading...
The last decade has seen the proliferation of multinational clinical trials having sites in six or more countries, often spanning two or even three continents. The expansion of clinical trials to previously untapped locations has had many benefits:
- Improved ability to maintain strong recruitment rates
- Advanced capability to file/launch a new drug in many markets quickly
Along with the benefits, the shift to large multinational studies has also introduced difficulties:
- Study teams are faced with increased logistical and administrative challenges
- Technical infrastructure, time zones, multiple languages and remote locations of sites create new obstacles for data collection and communication.
In this panel discussion, pharmaceutical industry professionals currently working on global clinical trials speak to these topics as well as strategies they have employed to execute their multinational trials successfully.
More Webcasts
IntraLinks Rings the Opening Bell at New York Stock Exchange
To celebrate our recent IPO, CEO Andrew Damico and the rest of the IntraLinks executive team rang the opening bell at the New York Stock Exchange (NYSE) on Monday, August 9. This video provides an in-depth look at what happened before, during and after the bell ringing, including a tour of NYSE and an interview with Andrew about the importance of the IPO.
Securing ReliABILITY: Buying and Selling a Business Through a Proper Due-Diligence Process
The 7th Annual Global M&A Conference was held in May in Mexico City, Mexico. This conference ioins private equity investors, corporate development directors, business owners and other members of the M&A community for the premier annual deal making and meeting place for insight into M&A transaction activity.
IntraLinks participated in the panel “Securing ReliABILITY: Buying and Selling a Business Through a Proper Due-Diligence Process” to discuss best practices for critical data exchange during the M&A process.
Trends, Challenges, and Technology Use in a Changing M&A Environment
Daniel Krauss, Forrester Analyst, discusses “Trends, Challenges, and Technology Use in a Changing M&A Environment”, including a presentation of the results of the survey. He speaks about what these results mean for M&A professionals and the deal market. Don’t miss this opportunity to interact directly with this leading analyst.
Podcast: M&A Q2 2010
As we come to the end of the first half of the year, the M&A year to date can be summarized in relatively positive terms. Global deal activity is looking up, with private equity in particular making an astounding comeback. In this mergermarket podcast, brought to you by IntraLinks, contributors analyse the global M&A market, explore the dealmaking landscape to date and provide an outlook for the coming six months.
Live Webcast Replay: An Outlook on Global M&A Activity
As dealmakers across the world re-enter the M&A marketplace, there is regional disparity. Professionals in Europe and the US, though more confident, have yet to see a large increase in dealmaking, whereas Asia-Pacific practitioners are riding high on the crest of a new wave of activity. With such differences, it is important for those involved in M&A to understand the global picture in order to identify and maximize opportunities.
In advance of the release of the latest IntraLinks survey entitled "Global M&A Survey - An Outlook on Global M&A Activity and Future Deal Flow", mergermarket and IntraLinks are hosting this complimentary webcast featuring expert speakers who will examine the report's key findings and discuss the latest trends in the global M&A landscape.